Interne link ProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10 mei 31, 2017 om 11:00 AM UTC
Interne link ProQR remembers co-founder Henri Termeer after his unexpected passing mei 15, 2017 om 11:00 AM UTC
Interne link ProQR to Present its Ophthalmology Pipeline at ARVO, Highlighting Programs in Leber’s Congenital Amaurosis Type 10 (LCA 10) and Usher Syndrome mei 01, 2017 om 11:00 AM UTC
Interne link ProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 Patients april 27, 2017 om 11:00 AM UTC
Interne link ProQR to Present at the Deutsche Bank Health Care Conference april 20, 2017 om 11:00 AM UTC
Interne link ProQR Announces the Grant of two Key Patents, protecting QR-010 for Cystic Fibrosis in the US and EU april 03, 2017 om 11:00 AM UTC
Interne link ProQR Appoints David M. Rodman, MD as Chief Development Strategy Officer maart 27, 2017 om 11:00 AM UTC
Interne link ProQR to Present at Two Upcoming Investor Conferences in March maart 01, 2017 om 12:00 PM UTC
Interne link ProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business Update februari 28, 2017 om 12:00 PM UTC
Interne link On a Shared Quest to Find Treatments for Rare Diseases, ProQR Supports Rare Disease Day februari 27, 2017 om 12:00 PM UTC
Interne link ProQR to Present at the LEERINK Partners Global Healthcare Conference februari 07, 2017 om 12:00 PM UTC
Interne link ProQR Announces that QR-010 Meets the Primary Endpoint in a Proof of Concept Study of Homozygous F508del Cystic Fibrosis Patients oktober 27, 2016 om 11:00 AM UTC
Interne link ProQR Announces Clinical Data Presentations and Investor & Analyst Event at NACFC september 27, 2016 om 11:00 AM UTC
Interne link ProQR to Present at Scientific and Investor Conferences in September september 06, 2016 om 11:00 AM UTC
Interne link ProQR Announces Results for the Second Quarter of 2016 augustus 17, 2016 om 11:00 AM UTC
Interne link ProQR Receives Fast Track Designation from FDA for QR-010 for Cystic Fibrosis juli 19, 2016 om 11:00 AM UTC
Interne link ProQR to Release Topline Data from Proof of Concept Study of QR-010 in Cystic Fibrosis Patients at NACFC juni 21, 2016 om 01:00 PM UTC
Interne link ProQR’s Drug Candidate QR-110 for Leber’s Congenital Amaurosis Type 10 Receives EMA and FDA Orphan Drug Designation juni 01, 2016 om 11:00 AM UTC
Interne link ProQR Announces Presentations at the European CF Conference and the JMP Life Science Conference juni 01, 2016 om 11:00 AM UTC
Interne link ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-110 for LCA10 at the 2016 ARVO Annual Meeting april 25, 2016 om 08:00 PM UTC